Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study

References

• MurrayCJOrtbladKFGuinovartCGlobal, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013Lancet201438499471005107025059949
   PubMed Web of Science ®Google Scholar
• DhedaKGumboTGandhiNRGlobal control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisLancet Respir Med20142432133824717628
   PubMed Web of Science ®Google Scholar
• TanneJHSome progress and some missed targets in the TB epidemicBMJ2014348g262624740907
   PubMedGoogle Scholar
• GlaziouPSismanidisCFloydKRaviglioneMGlobal epidemiology of tuberculosisCold Spring Harb Perspect Med201452a01779825359550
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGlobal Tuberculosis Report 2014Report No 9241564652Geneva, SwitzerlandWorld Health Organization2015
   Google Scholar
• RussellDGBarryCE3rdFlynnJLTuberculosis: what we don’t know can, and does, hurt usScience2010328598085285620466922
   PubMed Web of Science ®Google Scholar
• AlamiNNYuenCMMiramontesRTrends in tuberculosis − United States, 2013MMWR Morb Mortal Wkly Rep2014631122923324647398
   PubMed Web of Science ®Google Scholar
• TurnerRDBothamleyGHCough and the Transmission of TuberculosisJ Infect Dis201521191367137225387581
   PubMed Web of Science ®Google Scholar
• KulchavenyaEExtrapulmonary tuberculosis: are statistical reports accurate?Ther Adv Infect Dis201422617025165556
   PubMedGoogle Scholar
• ChaudharyPHepatobiliary tuberculosisAnn Gastroenterol201427320721124976240
   PubMedGoogle Scholar
• World Health OrganizationTreatment of Tuberculosis: Guidelines4th edGeneva, SwitzerlandWorld Health Organization2010
   Google Scholar
• ChanJGBaiXTrainiDAn update on the use of rifapentine for tuberculosis therapyExpert Opin Drug Deliv201411342143124397259
   PubMed Web of Science ®Google Scholar
• FieldSKFisherDJarandJMCowieRLNew treatment options for multidrug-resistant tuberculosisTher Adv Respir Dis20126525526822763676
   PubMed Web of Science ®Google Scholar
• China Tuberculosis Control CollaborationThe effect of tuberculosis control in ChinaLancet2004364943241742215288739
   PubMed Web of Science ®Google Scholar
• WangLZhangHRuanYTuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey dataLancet201438399342057206424650955
   PubMed Web of Science ®Google Scholar
• MillardJUgarte-GilCMooreDAMultidrug resistant tuberculosisBMJ2015350h88225721508
   PubMedGoogle Scholar
• GuntherGMultidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challengesClin Med201414327928524889573
   PubMed Web of Science ®Google Scholar
• JenkinsHETolmanAWYuenCMIncidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimatesLancet201438399281572157924671080
   PubMed Web of Science ®Google Scholar
• GoldsteinBPResistance to rifampicin: a reviewJ Antibiot (Tokyo)201467962563025118103
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGuidelines for the Programmatic Management of Drug-resistant Tuberculosis, 2011 UpdateGeneva, SwitzerlandWorld Health Organization2011
   Google Scholar
• MatteelliARoggiACarvalhoACExtensively drug-resistant tuberculosis: epidemiology and managementClin Epidemiol2014611111824729727
   PubMed Web of Science ®Google Scholar
• KakkarAKDahiyaNBedaquiline for the treatment of resistant tuberculosis: promises and pitfallsTuberculosis (Edinb)201494435736224841672
   PubMed Web of Science ®Google Scholar
• CoxELaessigKFDA approval of bedaquiline − the benefit-risk balance for drug-resistant tuberculosisN Engl J Med2014371868969125140952
   PubMed Web of Science ®Google Scholar
• WongEBCohenKABishaiWRRising to the challenge: new therapies for tuberculosisTrends Microbiol201321949350123764389
   PubMed Web of Science ®Google Scholar
• RyanNJLoJHDelamanid: first global approvalDrugs20147491041104524923253
   PubMed Web of Science ®Google Scholar
• KwonYSJeongBHKohWJDelamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerabilityExpert Opin Pharmacother201516225326125327169
   PubMed Web of Science ®Google Scholar
• BlairHAScottLJDelamanid: a review of its use in patients with multidrug-resistant tuberculosisDrugs20157519110025404020
   PubMed Web of Science ®Google Scholar
• SzumowskiJDLynchJBProfile of delamanid for the treatment of multidrug-resistant tuberculosisDrug Des Devel Ther20159677682
   PubMed Web of Science ®Google Scholar
• YeeDValiquetteCPelletierMParisienIRocherIMenziesDIncidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosisAm J Respir Crit Care Med2003167111472147712569078
   PubMed Web of Science ®Google Scholar
• ForgetEJMenziesDAdverse reactions to first-line antituberculosis drugsExpert Opin Drug Saf20065223124916503745
   PubMed Web of Science ®Google Scholar
• HosfordJDvon FrickenMELauzardoMHepatotoxicity from antituberculous therapy in the elderly: a systematic reviewTuberculosis (Edinb)201495211212225595441
   PubMed Web of Science ®Google Scholar
• ChoudharySKusum DeviVPotential of nanotechnology as a delivery platform against tuberculosis: current research reviewJ Control Release2015202C657525637706
   PubMedGoogle Scholar
• GriffithsGNystromBSableSBKhullerGKNanobead-based interventions for the treatment and prevention of tuberculosisNat Rev Microbiol201081182783420938454
   PubMed Web of Science ®Google Scholar
• BanyalSMalikPTuliHSMukherjeeTKAdvances in nanotechnology for diagnosis and treatment of tuberculosisCurr Opin Pulm Med201319328929723429097
   PubMed Web of Science ®Google Scholar
• DubeALemmerYHayeshiRState of the art and future directions in nanomedicine for tuberculosisExpert Opin Drug Deliv201310121725173424102208
   PubMed Web of Science ®Google Scholar
• KaurMGargTRathGGoyalAKCurrent nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosisCrit Rev Ther Drug Carrier Syst2014311498824579767
   PubMed Web of Science ®Google Scholar
• MehannaMMMohyeldinSMElgindyNARespirable nanocarriers as a promising strategy for antitubercular drug deliveryJ Control Release201418718319724878180
   PubMed Web of Science ®Google Scholar
• KaurIPSinghHNanostructured drug delivery for better management of tuberculosisJ Control Release2014184365024732260
   PubMed Web of Science ®Google Scholar
• VyasSPKhatriKLiposome-based drug delivery to alveolar macrophagesExpert Opin Drug Deliv200742959917335407
   PubMed Web of Science ®Google Scholar
• PinheiroMLucioMLimaJLReisSLiposomes as drug delivery systems for the treatment of TBNanomedicine (Lond)2011681413142822026379
   PubMed Web of Science ®Google Scholar
• PhamDDFattalETsapisNPulmonary drug delivery systems for tuberculosis treatmentInt J Pharm2015478251752925499020
   PubMed Web of Science ®Google Scholar
• BerringtonWRHawnTRMycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?Immunol Rev200721916718617850489
   PubMed Web of Science ®Google Scholar
• ZunigaJTorres-GarciaDSantos-MendozaTRodriguez-ReynaTSGranadosJYunisEJCellular and humoral mechanisms involved in the control of tuberculosisClin Dev Immunol2012201219392322666281
   PubMedGoogle Scholar
• TorradoECooperAMCytokines in the balance of protection and pathology during mycobacterial infectionsAdv Exp Med Biol201378312114023468107
   PubMed Web of Science ®Google Scholar
• MatucciAMaggiEVultaggioACellular and humoral immune responses during tuberculosis infection: useful knowledge in the era of biological agentsJ Rheumatol Suppl201491172324788996
   PubMedGoogle Scholar
• de MartinoMGalliLChiappiniEReflections on the immunology of tuberculosis: will we ever unravel the skein?BMC Infect Dis201414Suppl 1S124564297
   PubMedGoogle Scholar
• ParandhamanDKNarayananSCell death paradigms in the pathogenesis of Mycobacterium tuberculosis infectionFront Cell Infect Microbiol201443124634891
   PubMed Web of Science ®Google Scholar
• ChanJMehtaSBharrhanSThe role of B cells and humoral immunity in Mycobacterium tuberculosis infectionSemin Immunol201426658860025458990
   PubMed Web of Science ®Google Scholar
• UrdahlKBUnderstanding and overcoming the barriers to T cell-mediated immunity against tuberculosisSemin Immunol201426657858725453230
   PubMed Web of Science ®Google Scholar
• CooperAMCell-mediated immune responses in tuberculosisAnnu Rev Immunol20092739342219302046
   PubMed Web of Science ®Google Scholar
• RajaramMVNiBDoddCESchlesingerLSMacrophage immunoregulatory pathways in tuberculosisSemin Immunol201426647148525453226
   PubMed Web of Science ®Google Scholar
• BrunsHStengerSNew insights into the interaction of Mycobacterium tuberculosis and human macrophagesFuture Microbiol20149332734124762307
   PubMed Web of Science ®Google Scholar
• EtnaMPGiacominiESeveraMCocciaEMPro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesisSemin Immunol201426654355125453229
   PubMed Web of Science ®Google Scholar
• MoninLKhaderSAChemokines in tuberculosis: the good, the bad and the uglySemin Immunol201426655255825444549
   PubMed Web of Science ®Google Scholar
• DorhoiAKaufmannSHTumor necrosis factor-α in mycobacterial infectionSemin Immunol201426320320924819298
   PubMed Web of Science ®Google Scholar
• ToossiZEllnerJJThe role of TGFβ in the pathogenesis of human tuberculosisClin Immunol Immunopathol19988721071149614924
   PubMedGoogle Scholar
• FriedlandJSTargeting the inflammatory response in tuberculosisN Engl J Med2014371141354135625271609
   PubMed Web of Science ®Google Scholar
• WuMAungHHirschCSToossiZInhibition of Mycobacterium tuberculosis-induced signalling by transforming growth factor-β in human mononuclear phagocytesScand J Immunol201275330130422150316
   PubMed Web of Science ®Google Scholar
• Mayer-BarberKDAndradeBBOlandSDHost-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalkNature201451175079910324990750
   PubMed Web of Science ®Google Scholar
• JinWWangQWangZGengGComplete debridement for treatment of thoracolumbar spinal tuberculosis: a clinical curative effect observationSpine J201414696497024119880
   PubMed Web of Science ®Google Scholar
• WangZShiJGengGQiuHUltra-short-course chemotherapy for spinal tuberculosis: five years of observationEur Spine J201322227428123053764
   PubMed Web of Science ®Google Scholar
• WangZGeZJinWTreatment of spinal tuberculosis with ultrashort-course chemotherapy in conjunction with partial excision of pathologic vertebraeSpine J20077667168117998127
   PubMed Web of Science ®Google Scholar
• QinYZhouZWPanSTGraphene quantum dots induce apoptosis, autophagy, and inflammatory response via p38 mitogen-activated protein kinase and nuclear factor-kappaB mediated signaling pathways in activated THP-1 macrophagesToxicology2015327627625446327
   PubMed Web of Science ®Google Scholar
• YinJJSharmaSShumyakSPSynthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatmentPLoS One201385e6228923658721
   PubMed Web of Science ®Google Scholar
• LiYCHeSMHeZXPlumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cellsCancer Lett2014344223925924280585
   PubMed Web of Science ®Google Scholar
• DingYHZhouZWHaCFAlisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cellsDrug Des Devel Ther20159425464
   PubMed Web of Science ®Google Scholar
• YuanCXZhouZWYangYXInhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cellsDrug Des Devel Ther20159487508
   PubMed Web of Science ®Google Scholar
• ZhouZWLiXXHeZXInduction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cellsDrug Des Devel Ther2015915111554
   Web of Science ®Google Scholar
• QiuJXZhouZWHeZXPlumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cellsDrug Des Devel Ther20159349417
   PubMed Web of Science ®Google Scholar
• PanSTZhouZWHeZXProteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approachDrug Des Devel Ther20159937968
   PubMed Web of Science ®Google Scholar
• KoulHKPalMKoulSRole of p38 MAP kinase signal transduction in solid tumorsGenes Cancer201349–1034235924349632
   PubMedGoogle Scholar
• WagnerEFNebredaARSignal integration by JNK and p38 MAPK pathways in cancer developmentNat Rev Cancer20099853754919629069
   PubMed Web of Science ®Google Scholar
• BakerSJPTEN enters the nuclear ageCell20071281252817218252
   PubMed Web of Science ®Google Scholar
• KangRZehHJLotzeMTTangDThe Beclin 1 network regulates autophagy and apoptosisCell Death Differ201118457158021311563
   PubMed Web of Science ®Google Scholar
• GreenDRLevineBTo be or not to be? How selective autophagy and cell death govern cell fateCell20141571657524679527
   PubMed Web of Science ®Google Scholar
• HurleyJHSchulmanBAAtomistic autophagy: the structures of cellular self-digestionCell2014157230031124725401
   PubMed Web of Science ®Google Scholar
• Deschenes-SimardXKottakisFMelocheSFerbeyreGERKs in cancer: friends or foes?Cancer Res201474241241924408923
   PubMed Web of Science ®Google Scholar
• RamosJWThe regulation of extracellular signal-regulated kinase (ERK) in mammalian cellsInt J Biochem Cell Biol200840122707271918562239
   PubMed Web of Science ®Google Scholar
• Garcia-MoncoJCTuberculosisHandb Clin Neurol20141211485149924365432
   PubMedGoogle Scholar
• HorsburghCRJrTuberculosisEur Respir Rev201423131363924591660
   PubMedGoogle Scholar
• AllianceTStreptomycinTuberculosis (Edinb)200888216216318486061
   PubMedGoogle Scholar
• ChaissonREChurchyardGJRecurrent tuberculosis: relapse, reinfection, and HIVJ Infect Dis2010201565365520121432
   PubMed Web of Science ®Google Scholar
• SalemIIFlasherDLDuzgunesNLiposome-encapsulated antibioticsMethods Enzymol200539126129115721386
   PubMed Web of Science ®Google Scholar
• SarkarSSureshMRAn overview of tuberculosis chemotherapy – a literature reviewJ Pharm Pharm Sci201114214816121733406
   PubMed Web of Science ®Google Scholar
• WilczewskaAZNiemirowiczKMarkiewiczKHCarHNanoparticles as drug delivery systemsPharmacol Rep20126451020103723238461
   PubMed Web of Science ®Google Scholar
• KorbelDSSchneiderBESchaibleUEInnate immunity in tuberculosis: myths and truthMicrobes Infect2008109995100418762264
   PubMed Web of Science ®Google Scholar
• HelmuthLMicrobiology – a weak link in TB bacterium is foundScience200028954821123112510970221
   PubMed Web of Science ®Google Scholar
• OrmeIMBasarabaRJThe formation of the granuloma in tuberculosis infectionSemin Immunol201426660160925453231
   PubMed Web of Science ®Google Scholar
• EllnerJJImmunoregulation in TB: observations and implicationsClin Transl Sci201031232820443950
   PubMed Web of Science ®Google Scholar
• LiHLiangCZTaoYQShenCCChenQXElevated local TGF-β1 level predisposes a closed bone fracture to tuberculosis infectionMed Hypotheses201279340040222738905
   PubMed Web of Science ®Google Scholar
• CambierCJFalkowSRamakrishnanLHost evasion and exploitation schemes of Mycobacterium tuberculosisCell201415971497150925525872
   PubMed Web of Science ®Google Scholar
• CarthewRWSontheimerEJOrigins and mechanisms of miRNAs and siRNAsCell2009136464265519239886
   PubMed Web of Science ®Google Scholar
• LimaWFPrakashTPMurrayHMSingle-stranded siRNAs activate RNAi in animalsCell2012150588389422939618
   PubMed Web of Science ®Google Scholar
• HwangMKimH-JNohH-JTGF-β1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstructionExp Mol Pathol2006811485416443218
   PubMed Web of Science ®Google Scholar
• MannMFunctional and quantitative proteomics using SILACNat Rev Mol Cell Biol200671295295817139335
   PubMed Web of Science ®Google Scholar
• OngSEMannMA practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)Nat Protoc2006162650266017406521
   PubMed Web of Science ®Google Scholar